Literature DB >> 8628362

Angiotensin receptors and their antagonists.

T L Goodfriend1, M E Elliott, K J Catt.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8628362     DOI： 10.1056/NEJM199606203342507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  70 in total

Review 1.  Postinfarction left ventricular remodelling: where are the theories and trials leading us?

Authors:  Z R Yousef; S R Redwood; M S Marber
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

Review 2.  Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Authors:  J Vlachogiannakos; A K Tang; D Patch; A K Burroughs
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

3.  The renin-angiotensin system antagonism in the treatment of hypertension.

Authors:  J D Bisognano; R J Cody
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 4.  Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.

Authors:  R M Carey; Z Q Wang; H M Siragy
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

5.  Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing.

Authors:  A Alderborn; A Kristofferson; U Hammerling
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

Review 6.  ACE inhibitor-induced angioedema.

Authors:  Monali Vasekar; Timothy J Craig
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 7.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

8.  Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma.

Authors:  Rana R McKay; Gustavo E Rodriguez; Xun Lin; Marina D Kaymakcalan; Ole-Petter R Hamnvik; Venkata S Sabbisetti; Rupal S Bhatt; Ronit Simantov; Toni K Choueiri
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

9.  Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.

Authors:  Yajuan Qi; Kebin Zhang; Yuxin Wu; Zihui Xu; Qian Chen Yong; Rajesh Kumar; Kenneth M Baker; Qinglei Zhu; Shouwen Chen; Shaodong Guo
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

10.  Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions.

Authors:  Mark A Munger
Journal:  P T       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.